Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.

Get JAZZ alerts

About Neena M. Patil

Neena M. Patil is recorded as General Counsel at Jazz Pharmaceuticals plc (JAZZ). The newest filing on record that lists Neena M. Patil as General Counsel at Jazz Pharmaceuticals plc (JAZZ) is dated June 12, 2020. The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $6,299,539 for Neena M. Patil in fiscal 2025, including a base salary of $715,481. Disclosed compensation is on record for 4 fiscal years. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Jazz Pharmaceuticals plc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Jazz Pharmaceuticals plc (JAZZ) $715,481 $6,299,539
2024 Jazz Pharmaceuticals plc (JAZZ) $665,769 $4,309,074
2023 Jazz Pharmaceuticals plc (JAZZ) $673,945 $3,877,435
2019 Jazz Pharmaceuticals plc (JAZZ) $166,731 $3,205,781

Recent activity

No call appearances or filed executive changes recorded yet.